Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy–A meta-analysis

By Sher Amna   Wu Shenhong  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma

By Terheyden Patrick   Hofmann Maja   Weininger M.   Bröcker Eva-B.   Becker Jürgen  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 11, 2007-11 ,pp. : 897-901

Springer Publishing Company

Access to resources Recommend Favorite

Administration of anti-vascular endothelial growth factor antibody following hepatectomy does not inhibit remnant liver regeneration or growth of remnant metastases

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 347-350

Spandidos Publications

Access to resources Recommend Favorite

Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts

By Holloway Shane   Beck Adam   Shivakumar Latha   Shih Jessica   Fleming Jason   Brekken Rolf  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1145-1155

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite